Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FD930
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,699
Award facts
- Contract value 100% obligated
- $15,698.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,698.57 to AmerisourceBergen Drug Corp for the supply of Gardasil 9 Syringe 0.5ML, a human papillomavirus vaccine. The contract was awarded on November 18, 2025, with an ultimate completion date of November 19, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply comprehensive pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities on a competitive basis. This delivery order represents one of numerous transactions executed under the broader SPE2DX vehicle, which enables AmerisourceBergen to support global pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FD930?
SPE2DR26FD930 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FD930 worth?
The government has obligated $15,699 on SPE2DR26FD930.
Is contract SPE2DR26FD930 an order under another contract?
Yes. SPE2DR26FD930 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD930 competed?
The extent of competition for SPE2DR26FD930 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award